Youhong Hu

2.7k total citations
92 papers, 2.3k citations indexed

About

Youhong Hu is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Youhong Hu has authored 92 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Organic Chemistry, 30 papers in Molecular Biology and 27 papers in Pharmacology. Recurrent topics in Youhong Hu's work include Synthesis of Organic Compounds (23 papers), Catalytic C–H Functionalization Methods (19 papers) and Catalytic Alkyne Reactions (13 papers). Youhong Hu is often cited by papers focused on Synthesis of Organic Compounds (23 papers), Catalytic C–H Functionalization Methods (19 papers) and Catalytic Alkyne Reactions (13 papers). Youhong Hu collaborates with scholars based in China, United States and United Kingdom. Youhong Hu's co-authors include Gang Cheng, Fuchun Xie, Zhen Yang, Lizhi Zhao, Liguang Lou, Alan P. Kozikowski, Feng Hu, Reza Fathi, Hong Chen and Haiyan Zhang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and SHILAP Revista de lepidopterología.

In The Last Decade

Youhong Hu

89 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Youhong Hu China 28 1.3k 745 508 160 130 92 2.3k
Tuoping Luo China 33 1.8k 1.4× 1.1k 1.5× 314 0.6× 143 0.9× 192 1.5× 65 3.0k
Won‐Jea Cho South Korea 24 956 0.7× 1.1k 1.5× 226 0.4× 237 1.5× 98 0.8× 76 2.3k
Stephen C. Bergmeier United States 29 2.1k 1.6× 1.7k 2.3× 161 0.3× 198 1.2× 77 0.6× 103 3.6k
Hiroyuki Miyachi Japan 28 665 0.5× 1.1k 1.5× 238 0.5× 340 2.1× 110 0.8× 93 2.1k
Antonia F. Stepan United States 20 1.7k 1.3× 733 1.0× 224 0.4× 156 1.0× 165 1.3× 37 2.9k
John W. Clader United States 28 1.4k 1.0× 953 1.3× 203 0.4× 320 2.0× 189 1.5× 72 3.1k
Amaury Farce France 23 775 0.6× 935 1.3× 186 0.4× 263 1.6× 75 0.6× 71 1.9k
Vivek Asati India 23 1.4k 1.1× 1.1k 1.4× 275 0.5× 337 2.1× 48 0.4× 96 2.7k
Nicole Pouli Greece 18 850 0.6× 452 0.6× 228 0.4× 70 0.4× 142 1.1× 86 1.4k
Jingkang Shen China 29 1.0k 0.8× 1.6k 2.2× 406 0.8× 205 1.3× 188 1.4× 129 2.9k

Countries citing papers authored by Youhong Hu

Since Specialization
Citations

This map shows the geographic impact of Youhong Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Youhong Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Youhong Hu more than expected).

Fields of papers citing papers by Youhong Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Youhong Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Youhong Hu. The network helps show where Youhong Hu may publish in the future.

Co-authorship network of co-authors of Youhong Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Youhong Hu. A scholar is included among the top collaborators of Youhong Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Youhong Hu. Youhong Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Luyao, Y. N. Zhang, Jingjing Chen, et al.. (2025). Fine structural design of 3βHSD1 inhibitors for prostate cancer therapy. Proceedings of the National Academy of Sciences. 122(26). e2422267122–e2422267122. 2 indexed citations
2.
Zeng, Yanping, Jian Xiao, Shi Li, et al.. (2025). Discovery of 2,4-quinazolinedione derivatives as LC3B recruiters in the facilitation of protein complex degradations. European Journal of Medicinal Chemistry. 287. 117293–117293. 3 indexed citations
3.
Yang, Li, Ying Gong, Feifei Liu, et al.. (2023). A novel phthalazinone derivative as a capsid assembly modulator inhibits hepatitis B virus expression. Antiviral Research. 221. 105763–105763. 3 indexed citations
4.
Feng, Bo, et al.. (2022). Discovery of highly potent SARS-CoV-2 Mpro inhibitors based on benzoisothiazolone scaffold. Bioorganic & Medicinal Chemistry Letters. 58. 128526–128526. 15 indexed citations
5.
Ji, Xingyu, et al.. (2022). Protein C-Terminal Tyrosine Conjugation via Recyclable Immobilized BmTYR. ACS Omega. 7(44). 40532–40539. 2 indexed citations
6.
Xiang, Caigui, Xin Li, Fan Chen, et al.. (2021). Discovery of Potent Antiallergic Agents Based on an o-Aminopyridinyl Alkynyl Scaffold. Journal of Medicinal Chemistry. 64(18). 13588–13603. 1 indexed citations
7.
Guo, Shimeng, Xi Lin, Shanshan Li, et al.. (2020). Targeted Proteomics Combined with Affinity Mass Spectrometry Analysis Reveals Antagonist E7 Acts As an Intracellular Covalent Ligand of Orphan Receptor GPR52. ACS Chemical Biology. 15(12). 3275–3284. 10 indexed citations
8.
Wu, Bing, Yingqiang Liu, Linjiang Tong, et al.. (2020). Novel Class of Colony-Stimulating Factor 1 Receptor Kinase Inhibitors Based on an o-Aminopyridyl Alkynyl Scaffold as Potential Treatment for Inflammatory Disorders. Journal of Medicinal Chemistry. 63(3). 1397–1414. 24 indexed citations
9.
Cheng, Gang, et al.. (2017). One-pot Synthesis of 6-Aza-chromone Derivatives Through Cascade Carbonylation-Sonogashira-Cyclization. Scientific Reports. 7(1). 4398–4398. 4 indexed citations
10.
11.
Yu, Ye, Xiankun Tong, Pei‐Lan He, et al.. (2014). Discovering novel anti-HCV compounds with inhibitory activities toward HCV NS3/4A protease. Acta Pharmacologica Sinica. 35(8). 1074–1081. 12 indexed citations
12.
Luo, Yu, et al.. (2013). Synthesis and in vitro cytotoxic evaluation of novel $$N$$ -(3,4,5-trimethoxyphenyl)pyridin-2( $$1H$$ )-one derivatives. Molecular Diversity. 17(3). 435–444. 4 indexed citations
13.
Fu, Yan, et al.. (2013). Discovery of novel 2,6-disubstituted pyridazinone derivatives as acetylcholinesterase inhibitors. European Journal of Medicinal Chemistry. 63. 95–103. 37 indexed citations
14.
Wu, Qiong, et al.. (2012). p38 Mitogen-Activated Protein Kinase Is Required for the Antitumor Activity of the Vascular Disrupting Agent 5,6-Dimethylxanthenone-4-acetic Acid. Journal of Pharmacology and Experimental Therapeutics. 341(3). 709–717. 4 indexed citations
15.
Xie, Fuchun, et al.. (2011). Domino reactions of 2-methyl chromones containing an electron withdrawing group with chromone-fused dienes. Organic & Biomolecular Chemistry. 10(3). 486–489. 12 indexed citations
16.
Liu, Yang, Liping Huang, Fuchun Xie, Xuxing Chen, & Youhong Hu. (2011). Synthesis of novel functional polycyclic chromones through Michael addition and double cyclizations. Organic & Biomolecular Chemistry. 9(8). 2680–2680. 17 indexed citations
17.
Xie, Fuchun, Hong Chen, & Youhong Hu. (2010). Efficient Construction of a 3C-Xanthone-Linked 3C-Chromone Scaffold by Novel Double Michael Additions and Cyclizations. Organic Letters. 12(13). 3086–3089. 17 indexed citations
18.
Zhao, Lizhi, Gang Cheng, & Youhong Hu. (2008). A novel multicomponent reaction to synthesize substituted furo[3,2-c]chromenes via a Pd-catalyzed cascade process. Tetrahedron Letters. 49(52). 7364–7367. 37 indexed citations
19.
Lin, Shijun, et al.. (2007). Microwave-Enhanced Efficient Synthesis of Diversified 3,6-Disubstituted Pyridazines. Journal of Combinatorial Chemistry. 9(5). 742–744. 17 indexed citations
20.
Kozikowski, Alan P., Werner Tückmantel, & Youhong Hu. (2001). Studies in Polyphenol Chemistry and Bioactivity. 3.1,2 Stereocontrolled Synthesis of Epicatechin-4α,8-epicatechin, an Unnatural Isomer of the B-Type Procyanidins. The Journal of Organic Chemistry. 66(4). 1287–1296. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tuoping Luo Breakdown of academic impact, for papers by Won‐Jea Cho Breakdown of academic impact, for papers by Stephen C. Bergmeier Breakdown of academic impact, for papers by Hiroyuki Miyachi Breakdown of academic impact, for papers by Antonia F. Stepan Breakdown of academic impact, for papers by John W. Clader Breakdown of academic impact, for papers by Amaury Farce Breakdown of academic impact, for papers by Vivek Asati Breakdown of academic impact, for papers by Nicole Pouli Breakdown of academic impact, for papers by Jingkang Shen
Rankless by CCL
2026